Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial

Yan Lou, Lin Liu, Hangping Yao, Xingjiang Hu, Junwei Su, Kaijin Xu, Rui Luo, Xi Yang, Lingjuan He, Xiaoyang Lu, Qingwei Zhao, Tingbo Liang, Yunqing Qiu
doi: https://doi.org/10.1101/2020.04.29.20085761

Data Availability

The complete de-identified patient dataset, statistical plan, and consent forms will be made available on request to YQ Q (qiuyq{at}zju.edu.cn) 1 year after publication, with no time limit.

Back to top
Posted May 05, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial
Yan Lou, Lin Liu, Hangping Yao, Xingjiang Hu, Junwei Su, Kaijin Xu, Rui Luo, Xi Yang, Lingjuan He, Xiaoyang Lu, Qingwei Zhao, Tingbo Liang, Yunqing Qiu
medRxiv 2020.04.29.20085761; doi: https://doi.org/10.1101/2020.04.29.20085761
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools

Subject Area